Glumetza Buyers Get Cert. In Suit Over 800% Price Jump

By Dorothy Atkins · August 17, 2020, 7:04 PM EDT

A California federal judge on Friday certified a proposed class of diabetes drug buyers who accuse drugmakers of violating antitrust laws by blocking a generic version of Glumetza, saying it will...

To view the full article, register now.